01397nam a2200397 i 4500001001300000003000600013005001700019008004100036040002300077042000800100043001200108074000900120086002100129088002300150099002100173110004300194240003100237245006800268264007100336300002300407336000800430337001600438338001900454500003600473500003200509500002100541500002600562500002500588650006200613650005600675650005600731655003100787776014400818949001800962999001900980ocn963852181OCoLC20170826160050.0161121s2016    dcu      l   f000 0 eng c  aGPObengerdacGPO  apcc  an-us---  a05750 aAE 2.110:114-229  aPublic Law 114-229  aAE 2.110:114-2291 aUnited States,eenacting jurisdiction.10aAdvancing Hope Act of 201613aAn Act to Extend the Pediatric Priority Review Voucher Program. 1a[Washington, D.C.] :b[U.S. Government Publishing Office],c[2016]  a[4] pages ;c24 cm  btxt  bn2rdamedia  bnc2rdacarrier  aShipping list no.: 2017-0061-P.  a"Sept. 29, 2016 (S. 1878)."  a"130 Stat. 943."  a"Public Law 114-229."  aCRDP Project record. 0aPediatric pharmacologyxGovernment policyzUnited States. 0aDrugsxTestingxLaw and legislationzUnited States. 0aDrug developmentxGovernment policyzUnited States. 7aStatutes and codes.2lcgft08iOnline version:aUnited States.sAdvancing Hope Act of 2016.tAct to Extend the Pediatric Priority Review Voucher Programw(OCoLC)962731777  aBEVbFed Docs  c265326d265326